L ichen planus frequently involves the esophagus, does not respond well to medications, and commonly leads to stricture formation. 1, 2 Recently, IgG4 was shown to be present in the epithelium in eosinophilic esophagitis 3 and to be associated with esophageal stricture formation in IgG4 disease. 4 The aim of this study was to determine if tissue IgG4 is present in esophageal lichen planus as a marker of esophageal fibrosis.
Methods
The Mayo Clinic patient database was searched for patients diagnosed with esophageal lichen planus from 1994 to 2016 by criteria described previously.
1 Severe (vs mild) fibrostenotic esophageal lichen planus was defined by any stricture greater than 4 cm, or total combined stricture lengths greater than 4 cm if present in multiple locations by endoscopy and radiography. Immunohistochemistry for IgG4 was performed on formalin-fixed, paraffin-embedded tissue obtained at index endoscopy. The mouse monoclonal primary antibody produced by Cell Marque (MRQ-44) (Sigma, St. Louis, MO) was used, in conjunction with a Ventana Roche (Tucson, AZ) automated slide stainer. IgG4-positive plasma cells were counted at a magnification of 400Â (field diameter, 0.625 mm). IgG4 counts were categorized into 1þ, 2þ, 3þ, and 4þ groups by cell count. Either the chi-square or the Fisher exact test, a 2-sample t test, or the Wilcoxon rank-sum test were used where appropriate. SAS statistical software version 9.4 was used (SAS Institute, Inc, Cary, NC).
Results
Fifty-eight patients with esophageal lichen planus were identified with 29 patients excluded owing to a lack of reviewable histology, barium swallow, or clear findings of lichen planus. Twenty-two patients had classic esophageal lichen planus based on histology and endoscopy with extraesophageal lichen planus. The extraesophageal sites most commonly involved were genital (61.5%), oral (58.6%), and skin (10.3%). Six patients had classic disease limited to the esophagus, and 1 patient had classic endoscopic findings and a high clinical suspicion for esophageal lichen planus. Patients were predominantly female (75%), white (100%), with a median age of 63 years (43-84 y). Seven patients were characterized as having mild disease and 22 patients had severe fibrostenotic esophageal lichen planus (12 patients with small-caliber esophagus). Notably, endoscopy missed strictures in 5 patients seen on esophagography.
Esophageal biopsy specimens from patients with lichen planus ( Figure 1A and B) showed the presence of a lichenoid reaction, increased lymphocytes, neutrophils, eosinophils, inflammation, and fibrosis of the lamina propria and ulceration ( Figure 1C and D) . IgG4 staining was variable in patients ( Figure 1E and F) . Twelve of 29 patients had positive IgG4 staining. There was a predominant cellular distribution confined to the lamina propria. An acellular distribution of IgG4 also was found in the esophageal epithelium. This IgG4 staining had a characteristic beading appearance in the intercellular spaces. Biopsy specimens from 45.5% (10 of 22) of patients in the severe fibrostenotic group showed positive staining for IgG4. In contrast, 0 of 7 patients in the mild group had IgG4 staining with a trend toward statistical significance (P ¼ .063). The median number of IgG4-positive cells also was greater in the severe group (14.6 AE 27.2) vs 0.0 (0.0) in the mild group (P ¼ .038). The degree of IgG4 staining was noted to be 1þ in 2 of 12, 2þ in 1 of 12, 3þ in 2 of 12, and 4þ in 5 of 12. The number of positive cells per high-powered field ranged from 0 to 100 cells. For the 18 patients with lamina propria (fibrosis located) present on biopsy, 66.7% (10 of 15) of patients in the severe group were positive for IgG4 compared with 0 of the 3 patients in the mild group (P ¼ .069). The presence of extraesophageal manifestations or oral involvement with lichen planus did not correlate to the presence of IgG4 in esophageal biopsy specimens.
Discussion
In this study we showed that IgG4-positive plasma cells commonly are present in the lamina propria in patients with esophageal lichen planus. Furthermore, disease severity tended to correlate with positive IgG4 staining with a statistically significant difference in mean IgG4-positive cell count between mild and severe stricturing groups. Nevertheless, the relationship of IgG4 antibody to lichen planus pathogenesis is unclear. Furthermore, it also is unclear if the finding of IgG4 in a minority of our patients indicates a patchy distribution, technical limitations, or a distinct IgG4-mediated pathophysiology that applies to a specific subset of patients with lichen planus. Unfortunately, there were no other characteristics of the disease such as extraesophageal involvement that predicted the presence of IgG4 in cells.
These findings raise the question of whether therapies used for IgG4-related disease, such as rituximab 5 or systemic steroids, 6 could be applicable to esophageal lichen planus when tissue IgG4 is detected. This is particularly needed in esophageal lichen planus, in which data on medical therapy are limited or ineffective, necessitating multiple esophageal dilations that carry significant risk. 
